Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1992 Nov;77(3):345–353.

Hodgkin's disease cell lines: a model for interleukin-1-independent accessory cell function.

J L McKenzie 1, W Egner 1, V L Calder 1, D N Hart 1
PMCID: PMC1421707  PMID: 1478681

Abstract

The haemopoietic origins of the Hodgkin's disease (HD)-derived cell lines L428, KM-H2 and HDLM-2 remain controversial. Analysis of T-cell receptor (TcR) and Ig rearrangements cannot resolve this, and lineage promiscuity limits the interpretation of isolated surface antigen expression. Nonetheless the cell marker profile of L428 has similarities with human dendritic cells (DC), and L428 strongly stimulates in the mixed leucocyte reaction (MLR). We therefore undertook an extended immunophenotypic comparison of the HD lines with that recently defined for DC, prior to examining their ability to stimulate allogenic T lymphocytes, and comparing the molecular interactions involved with those of primary MLR stimulatory cells. The immunophenotype of the HD lines failed to establish either a lymphoid or monocytoid derivation. The profile of L428 appeared similar to the human DC. All three lines were potent stimulators in the primary MLR, and each expressed relevant adhesion and signal-transducing molecules important for co-stimulating T lymphocytes. Inhibition studies using monoclonal antibodies indicated similar contributions within HD line-T cell MLR to that documented in human tonsil DC-T cell MLR. The HD lines produced no detectable interleukin-1 (IL-1) by biological or immunological analysis. Moreover they stimulated allogeneic T lymphocytes in the presence of anti-IL-1 antibodies. Thus although IL-1 mRNA can be detected in both HDLM-2 and KM-H2 by polymerase chain reaction, these lines, and L428, share with DC the ability to stimulate allogeneic T lymphocytes in an IL-1-independent manner [corrected]. HD lines, particularly L428, may provide a standardized, reproducible, IL-1-independent model for dissection of the co-stimulatory requirements of the human primary MLR.

Full text

PDF
345

Images in this article

351Figure 3
on p.351

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Austyn J. M. Lymphoid dendritic cells. Immunology. 1987 Oct;62(2):161–170. [PMC free article] [PubMed] [Google Scholar]
  2. Chua A. O., Gubler U. Sequence of the cDNA for the human fibroblast type interleukin-1 receptor. Nucleic Acids Res. 1989 Dec 11;17(23):10114–10114. doi: 10.1093/nar/17.23.10114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Drexler H. G., Leber B. F., Norton J., Yaxley J., Tatsumi E., Hoffbrand A. V., Minowada J. Genotypes and immunophenotypes of Hodgkin's disease-derived cell lines. Leukemia. 1988 Jun;2(6):371–376. [PubMed] [Google Scholar]
  4. Eisenberg S. P., Brewer M. T., Verderber E., Heimdal P., Brandhuber B. J., Thompson R. C. Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism. Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5232–5236. doi: 10.1073/pnas.88.12.5232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ellis T. M., McMannis J. D., Chua A. O., Gubler U., Fisher R. I. Interleukin-1-independent activation of human T lymphocytes stimulated by anti-CD3 and a Hodgkin's disease cell line with accessory cell activity. Cell Immunol. 1988 Oct 15;116(2):352–366. doi: 10.1016/0008-8749(88)90237-7. [DOI] [PubMed] [Google Scholar]
  6. Fisher R. I., Bates S. E., Bostick-Bruton F., Tuteja N., Diehl V. Neoplastic cells obtained from Hodgkin's disease function as accessory cells for mitogen-induced human T cell proliferative responses. J Immunol. 1984 May;132(5):2672–2677. [PubMed] [Google Scholar]
  7. Fisher R. I., Bostick-Bruton F., Sauder D. N., Scala G., Diehl V. Neoplastic cells obtained from Hodgkin's disease are potent stimulators of human primary mixed lymphocyte cultures. J Immunol. 1983 Jun;130(6):2666–2670. [PubMed] [Google Scholar]
  8. Fisher R. I., Cossman J., Diehl V., Volkman D. J. Antigen presentation by Hodgkin's disease cells. J Immunol. 1985 Nov;135(5):3568–3571. [PubMed] [Google Scholar]
  9. Geppert T. D., Davis L. S., Gur H., Wacholtz M. C., Lipsky P. E. Accessory cell signals involved in T-cell activation. Immunol Rev. 1990 Oct;117:5–66. doi: 10.1111/j.1600-065x.1990.tb00566.x. [DOI] [PubMed] [Google Scholar]
  10. Hart D. N., McKenzie J. L. Isolation and characterization of human tonsil dendritic cells. J Exp Med. 1988 Jul 1;168(1):157–170. doi: 10.1084/jem.168.1.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hsu S. M., Hsu P. L. Aberrant expression of T cell and B cell markers in myelocyte/monocyte/histiocyte-derived lymphoma and leukemia cells. Is the infrequent expression of T/B cell markers sufficient to establish a lymphoid origin for Hodgkin's Reed-Sternberg cells? Am J Pathol. 1989 Jan;134(1):203–212. [PMC free article] [PubMed] [Google Scholar]
  12. Hsu S. M., Hsu P. L. Lymphocyte functional antigens stabilize agglutination between Reed-Sternberg cells and T cells, but are not responsible for homotypic binding of Hodgkin's Reed-Sternberg cells. Am J Pathol. 1990 Sep;137(3):563–574. [PMC free article] [PubMed] [Google Scholar]
  13. Inaba K., Steinman R. M. Monoclonal antibodies to LFA-1 and to CD4 inhibit the mixed leukocyte reaction after the antigen-dependent clustering of dendritic cells and T lymphocytes. J Exp Med. 1987 May 1;165(5):1403–1417. doi: 10.1084/jem.165.5.1403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kennedy I. C., Hart D. N., Colls B. M., Nimmo J. C., Willis D. A., Angus H. B. Nodular sclerosing, mixed cellularity and lymphocyte-depleted variants of Hodgkin's disease are probable dendritic cell malignancies. Clin Exp Immunol. 1989 Jun;76(3):324–331. [PMC free article] [PubMed] [Google Scholar]
  15. King P. D., Katz D. R. Human tonsillar dendritic cell-induced T cell responses: analysis of molecular mechanisms using monoclonal antibodies. Eur J Immunol. 1989 Apr;19(4):581–587. doi: 10.1002/eji.1830190402. [DOI] [PubMed] [Google Scholar]
  16. Kortmann C., Burrichter H., Monner D., Jahn G., Diehl V., Peter H. H. Interleukin-1-like activity constitutively generated by Hodgkin derived cell lines. I. Measurement in a human lymphocyte co-stimulator assay. Immunobiology. 1984 May;166(3):318–333. doi: 10.1016/s0171-2985(84)80049-2. [DOI] [PubMed] [Google Scholar]
  17. Krieger J. I., Chesnut R. W., Grey H. M. Capacity of B cells to function as stimulators of a primary mixed leukocyte reaction. J Immunol. 1986 Nov 15;137(10):3117–3123. [PubMed] [Google Scholar]
  18. Masters J. N., Attardi G. The nucleotide sequence of the cDNA coding for the human dihydrofolic acid reductase. Gene. 1983 Jan-Feb;21(1-2):59–63. doi: 10.1016/0378-1119(83)90147-6. [DOI] [PubMed] [Google Scholar]
  19. McKenzie D. Alloantigen presentation by B cells. Requirement for IL-1 and IL-6. J Immunol. 1988 Nov 1;141(9):2907–2911. [PubMed] [Google Scholar]
  20. McKenzie J. L., Prickett T. C., Hart D. N. Human dendritic cells stimulate allogeneic T cells in the absence of IL-1. Immunology. 1989 Jul;67(3):290–297. [PMC free article] [PubMed] [Google Scholar]
  21. Metlay J. P., Puré E., Steinman R. M. Distinct features of dendritic cells and anti-Ig activated B cells as stimulators of the primary mixed leukocyte reaction. J Exp Med. 1989 Jan 1;169(1):239–254. doi: 10.1084/jem.169.1.239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Paietta E., Stockert R. J., McManus M., Thompson D., Schmidt S., Wiernik P. H. Hodgkin's cell lectin, a lymphocyte adhesion molecule and mitogen. J Immunol. 1989 Nov 1;143(9):2850–2857. [PubMed] [Google Scholar]
  23. Prickett T. C., McKenzie J. L., Hart D. N. Characterization of interstitial dendritic cells in human liver. Transplantation. 1988 Nov;46(5):754–761. doi: 10.1097/00007890-198811000-00024. [DOI] [PubMed] [Google Scholar]
  24. Sanders M. E., Makgoba M. W., Sussman E. H., Luce G. E., Cossman J., Shaw S. Molecular pathways of adhesion in spontaneous rosetting of T-lymphocytes to the Hodgkin's cell line L428. Cancer Res. 1988 Jan 1;48(1):37–40. [PubMed] [Google Scholar]
  25. Scheeren R. A., Koopman G., Van der Baan S., Meijer C. J., Pals S. T. Adhesion receptors involved in clustering of blood dendritic cells and T lymphocytes. Eur J Immunol. 1991 May;21(5):1101–1105. doi: 10.1002/eji.1830210503. [DOI] [PubMed] [Google Scholar]
  26. Sorg R., Enczmann J., Sorg U., Heermeier K., Schneider E. M., Wernet P. Rapid and sensitive mRNA phenotyping for interleukins (IL-1 to IL-6) and colony-stimulating factors (G-CSF, M-CSF, and GM-CSF) by reverse transcription and subsequent polymerase chain reaction. Exp Hematol. 1991 Oct;19(9):882–887. [PubMed] [Google Scholar]
  27. Springer T. A. Adhesion receptors of the immune system. Nature. 1990 Aug 2;346(6283):425–434. doi: 10.1038/346425a0. [DOI] [PubMed] [Google Scholar]
  28. Vakkila J., Sihvola M., Hurme M. Human peripheral blood-derived dendritic cells do not produce interleukin 1 alpha, interleukin 1 beta, or interleukin 6. Scand J Immunol. 1990 Mar;31(3):345–352. doi: 10.1111/j.1365-3083.1990.tb02777.x. [DOI] [PubMed] [Google Scholar]
  29. Weaver C. T., Hawrylowicz C. M., Unanue E. R. T helper cell subsets require the expression of distinct costimulatory signals by antigen-presenting cells. Proc Natl Acad Sci U S A. 1988 Nov;85(21):8181–8185. doi: 10.1073/pnas.85.21.8181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Young J. W., Steinman R. M. Accessory cell requirements for the mixed-leukocyte reaction and polyclonal mitogens, as studied with a new technique for enriching blood dendritic cells. Cell Immunol. 1988 Jan;111(1):167–182. doi: 10.1016/0008-8749(88)90061-5. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES